ABSTRACT
Although pancreatic transplantation could be carried out for diabetes alone, current medical opinion suggests that the hazards and effects of immunosuppression outweigh the advantages. In patients receiving renal transplants for renal failure caused by diabetic nephropathy, immunosuppression will be given to protect the renal allograft and the same regimen will protect the pancreatic allograft. At present, therefore, pancreatic transplantation is combined with renal transplantation in these patients and both organs are monitored ultrasonically in similar ways. It is therefore appropriate to discuss pancreatic transplantation in this text.
